Marked ploidy and BCR-ABL gene amplification in vivo in a patient treated with STI571.
Sirulink
A
A
Silver
R T
RT
Najfeld
V
V
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001549:Benzamides; D004791:Enzyme Inhibitors / Q000009:adverse effects; D005260:Female; D016044:Fusion Proteins, bcr-abl / Q000037:antagonists & inhibitors / Q000235:genetics*; D005784:Gene Amplification; D006801:Humans; D000068877:Imatinib Mesylate; D007621:Karyotyping; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy / Q000235:genetics*; D008875:Middle Aged; D010677:Philadelphia Chromosome; D010879:Piperazines / Q000009:adverse effects*; D011003:Ploidies; D011743:Pyrimidines / Q000009:adverse effects*
D000970:Antineoplastic Agents; D001549:Benzamides; D004791:Enzyme Inhibitors; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D016044:Fusion Proteins, bcr-abl